Natalia Cuesta

Dr. Natalia Cuesta

Cell Biology, Universidad Complutense de Madrid, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2011 in Immunology & Cell Biology
Verified
Journal Article
Open access
PDF file
VSVinatha Sreeramkumar
Vinatha Sreeramkumar
MFManuel Fresno
Manuel Fresno
Natalia CuestaNatalia Cuesta
Natalia Cuesta
Our understanding of the key players involved in the differential regulation of T‐cell responses during inflammation, infection and auto‐immunity is fundamental for designing efficient therapeutic strategies against immune diseases. With respect to this, the inhibitory role of the lipid mediator prostaglandin E2(PGE2) in T‐cell immunity has been documented since the 1970s. Studies that ensued investigating the underlying mechanisms substantiated the suppressive function of micromolar concentrations of PGE2in T‐cell activation, proliferation, differentiation and migration. However, the past decade has seen a revolution in this perspective, since nanomolar concentrations of PGE2have been shown to potentiate Th1 and Th17 responses and aid in T‐cell proliferation. The understanding of concentration‐specific effects of PGE2in other cell types, the development of mice deficient in each subtype of the PGE2receptors (EP receptors) and the delineation of signalling pathways mediated by the EP receptors have enhanced our understanding of PGE2as an immune‐stimulator. PGE2regulates a multitude of functions in T‐cell activation and differentiation and these effects vary depending on the micro‐environment of the cell, maturation and activation state of the cell, type of EP receptor involved, local concentration of PGE2and whether it is a homeostatic or inflammatory scenario. In this review, we compartmentalize the various aspects of this complex relationship of PGE2with T lymphocytes. Given the importance of this molecule in T‐cell activation, we also address the possibility of using EP receptor antagonism as a potential therapeutic approach for some immune disorders.

15 July 2003 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MMMichael Martin
Michael Martin
RSRobert E Schifferle
Robert E Schifferle
Natalia CuestaNatalia Cuesta
Natalia Cuesta
SVStefanie N. Vogel
Stefanie N. Vogel
JKJannet Katz
Jannet Katz
SMSuzanne M. Michalek
Suzanne M. Michalek
Stimulation of the APC by Porphyromonas gingivalis LPS has been shown to result in the production of certain pro- and anti-inflammatory cytokines. However, the signaling pathways that regulate these processes are currently unknown. In the present study, the role of the phosphatidylinositol 3 kinase (PI3K)-Akt pathway in regulating P. gingivalis LPS-induced production of IL-10, IL-12 p40, and IL-12 p70 by human monocytes was investigated. P. gingivalis LPS selectively activates the PI3K-Akt pathway via Toll-like receptor 2, and inhibition of this pathway results in an abrogation of extracellular signal-regulated kinase 1/2 phosphorylation, whereas the activation of p38 and c-Jun N-terminal kinase 1/2 kinases were unaffected. Analysis of cytokine production following stimulation of monocytes with P. gingivalis LPS revealed that inhibition of the PI3K pathway differentially regulated IL-10 and IL-12 synthesis. IL-10 production was suppressed, whereas IL-12 levels were enhanced. Inhibition of P. gingivalis LPS-mediated activation of the PI3K-Akt pathway resulted in a pronounced augmentation of NF-κB p65 that was independent of IκB-α degradation. Furthermore, the ability of the PI3K-Akt pathway to modulate IL-10 and IL-12 production appears to be mediated by the selective suppression of extracellular signal-regulated kinase 1/2 activity, as the MEK1 inhibitor PD98059 closely mimicked the effects of wortmannin and LY294002 to differentially regulate IL-10 and IL-12 production by P. gingivalis LPS-stimulated monocytes. These studies provide new insight into how engagement of the PI3K-Akt pathway by P. gingivalis LPS affects the induction of key immunoregulatory cytokines that control both qualitative and quantitative aspects of innate and adaptive immunity.

3 June 2003 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
KHKurt A Heldwein
Kurt A Heldwein
MLMichael D. Liang
Michael D. Liang
TATonje K. Andresen
Tonje K. Andresen
KTKaren E Thomas
Karen E Thomas
AMAileen M. Marty
Aileen M. Marty
MFMatthew J. Fenton
Matthew J. Fenton
Toll-like receptor (TLR) proteins mediate cellular activation by microbes and microbial products. To delineate the role of TLR proteins in the development of host immune responses against mycobacteria, wild-type and TLR-deficient mice were infected with nonpathogenic Mycobacterium bovis bacillus Calmette-Guerin (BCG). Two weeks after intraperitoneal challenge with BCG, few bacilli were present in the lungs of wild-type and TLR4−/− mice, whereas bacterial loads were tenfold higher in the lungs of infected TLR2−/− mice. BCG challenge in vitro strongly induced proinflammatory cytokine secretion by macrophages from wild-type and TLR4−/− mice but not by TLR2−/− macrophages. In contrast, intracellular uptake, intracellular bacterial growth, and suppression of intracellular bacterial growth in vitro by interferon-γ (IFN-γ) were similar in macrophages from all three mouse strains, suggesting that BCG growth in the lungs of TLR2−/− mice was a consequence of defective adaptive immunity. Antigenic stimulation of splenocytes from infected wild-type and TLR4−/− mice induced T cell proliferation in vitro, whereas T cells from TLR2−/− mice failed to proliferate. Unexpectedly, activated CD4+ T cells from both TLR-deficient mouse strains secreted little IFN-γ in vitro compared with control T cells. A role for TLR4 in the control of bacterial growth and IFN-γ production in vivo was observed only when mice were infected with higher numbers of BCG. Thus, TLR2 and TLR4 appear to regulate distinct aspects of the host immune response against BCG.

1 December 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
Jonathan SoboloffJonathan Soboloff
Jonathan Soboloff
MSMaria Spassova
Maria Spassova
WXWen Xu
Wen Xu
LHLi-Ping He
Li-Ping He
Natalia CuestaNatalia Cuesta
Natalia Cuesta
DGDonald L. Gill
Donald L. Gill
The ubiquitously expressed canonical transient receptor potential (TRPC) ion channels are considered important in Ca2+ signal generation, but their mechanisms of activation and roles remain elusive. Whereas most studies have examined overexpressed TRPC channels, we used molecular, biochemical, and electrophysiological approaches to assess the expression and function of endogenous TRPC channels in A7r5 smooth muscle cells. Real time PCR and Western analyses reveal TRPC6 as the only member of the diacylglycerol-responsive TRPC3/6/7 subfamily of channels expressed at significant levels in A7r5 cells. TRPC1, TRPC4, and TRPC5 were also abundant. An outwardly rectifying, nonselective cation current was activated by phospholipase C-coupled vasopressin receptor activation or by the diacylglycerol analogue, oleoyl-2-acetyl-sn-glycerol (OAG). Introduction of TRPC6 small interfering RNA sequences into A7r5 cells by electroporation led to 90% reduction of TRPC6 transcript and 80% reduction of TRPC6 protein without any detectable compensatory changes in the expression of other TRPC channels. The OAG-activated nonselective cation current was similarly reduced by TRPC6 RNA interference. Intracellular Ca2+ measurements using fura-2 revealed that thapsigargin-induced store-operated Ca2+ entry was unaffected by TRPC6 knockdown, whereas vasopressin-induced Ca2+ entry was suppressed by more than 50%. In contrast, OAG-induced Ca2+ transients were unaffected by TRPC6 knockdown. Nevertheless, OAG-induced Ca2+ entry bore the hallmarks of TRPC6 function; it was inhibited by protein kinase C and blocked by the Src-kinase inhibitor, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2). Importantly, OAG-induced Ca2+ entry was blocked by the potent L-type Ca2+ channel inhibitor, *nimodipine. Thus, TRPC6 activation probably results primarily in Na ion entry and depolarization, leading to activation of L-type channels as the mediators of Ca2+ entry. Calculations reveal that even 90% reduction of TRPC6 channels would allow depolarization sufficient to activate L-type channels. This tight coupling between TRPC6 and L-type channels is probably important in mediating smooth muscle cell membrane potential and muscle contraction.

23 May 2011 in Archives of Physiology and Biochemistry
Verified
Journal Article
Closed access
PDF file
MFManuel Fresno
Manuel Fresno
RARuth Alvarez
Ruth Alvarez
Natalia CuestaNatalia Cuesta
Natalia Cuesta
Obesity is a highly prevalent health problem in Western countries that leads to many important diseases such as type 2 diabetes and metabolic syndrome being now considered an inflammatory chronic disease. Adipocytes are no longer considered passive cells storing fat since they are major producers of inflammatory cytokines during obesity. Adipocytes and macrophages share many biological properties including the synthesis of similar molecules regulating inflammation. Fatty acid levels are elevated in obesity and induce inflammatory pathways by yet a mostly unknown mechanism, leading to the development of insulin and leptin resistance. Recent studies suggest that these effects could be mediated through the activation of toll-like receptors (TLR). TLR signalling pathways might contribute to the development of obesity-associated insulin resistance, thus representing a connection between innate immunity and metabolism. Here, we summarize the recent evidence for the important role that TLRs play in adipose tissue, obesity and insulin resistance.

2 January 2008 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
EZEnrique Zudaire
Enrique Zudaire
Natalia CuestaNatalia Cuesta
Natalia Cuesta
VMVundavalli Murty
Vundavalli Murty
KWKaren Woodson
Karen Woodson
LALisa Adams
Lisa Adams
FCFrank Cuttitta
Frank Cuttitta
The aryl hydrocarbon receptor repressor (AHRR) is a bHLH/Per-ARNT-Sim transcription factor located in a region of chromosome 5 (5p15.3) that has been proposed to contain one or more tumor suppressor genes. We report here consistent downregulation of AHRR mRNA in human malignant tissue from different anatomical origins, including colon, breast, lung, stomach, cervix, and ovary, and demonstrate DNA hypermethylation as the regulatory mechanism of AHRR gene silencing. Knockdown of AHRR gene expression in a human lung cancer cell line using siRNA significantly enhanced in vitro anchorage-dependent and -independent cell growth as well as cell growth after transplantation into immunocompromised mice. In addition, knockdown of AHRR in non-clonable normal human mammary epithelial cells enabled them to grow in an anchorage-independent manner. Further, downregulation of AHRR expression in the human lung cancer cell line conferred resistance to apoptotic signals and enhanced motility and invasion in vitro and angiogenic potential in vivo. Ectopic expression of AHRR in tumor cells resulted in diminished anchorage-dependent and -independent cell growth and reduced angiogenic potential. These results therefore demonstrate that AHRR is a putative new tumor suppressor gene in multiple types of human cancers.